1-10 of 10
Jan Geissler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib (ASC) Add-on to Imatinib (IMA) Demonstrates Sustained High Rates of Ongoing Therapy and Deep Molecular Responses (DMRs) with Prolonged Follow-up in the ASC4MORE Study

Timothy P Hughes, Giuseppe Saglio, Jan Geissler, Dong-Wook Kim, Elza Lomaia, Jiri Mayer, Anna Turkina, Shruti Kapoor, Ana Paula Torres Cardoso, Jomy Jose, Monali Sura, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 866.
https://doi.org/10.1182/blood-2023-182100
Published: 2023
Journal Articles

Differences in Experiences Reported By Patients with Acute and Chronic Leukemia: A Global Survey

Zack Pemberton-Whiteley, Samantha Nier, Jan Geissler, Sophie Wintrich, Anne-Pierre Pickaert, Sam Salek, Esther Natalie Oliva, Tatiana I. Ionova, Jennie Bradley
Journal: Blood
Blood (2022) 140 (Supplement 1): 13273–13275.
https://doi.org/10.1182/blood-2022-163466
Published: 2022
Journal Articles

Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies within the Framework of Harmony and Harmony PLUS Projects

Katharina M Lang, Tamás Bereczky, Jan Geissler, Natacha Bolanos, Kathryn E. Morgan, Ananda Plate, Ana Vallejo, Sophie Wintrich, Nick York, Peter Loffelhardt, Brian Huntly, Pieter Sonneveld, Mario Boccadoro, Valeria Santini, Šárka Pospíšilová, Andreas Hochhaus, Tiziano Barbui, Peter Borchmann, Christian Buske, Yann Guillevic, Frederico Calado, Katy Harrison, Dalia Dawoud, Guillermo Sanz, Jesús María Hernández, Ellen De Waal, Martje Barbus, Renate Schulze-Rath, Lars Bullinger
Journal: Blood
Blood (2022) 140 (Supplement 1): 5285–5287.
https://doi.org/10.1182/blood-2022-157549
Published: 2022
Journal Articles

Efficacy and Safety Results from ASC4MORE, a Randomized Study of Asciminib (ASC) Add-on to Imatinib (IMA), Continued IMA, or Switch to Nilotinib (NIL) in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Not Achieving Deep Molecular Responses (DMRs) with ≥1 Year of IMA

Jorge E. Cortes, Timothy Hughes, Jan Geissler, Dong-Wook Kim, Elza Lomaia, Jiri Mayer, Anna G. Turkina, Sarah Hurwicz Kogut, Ana Paula Torres Cardoso, Monali Sura, Giuseppe Saglio
Journal: Blood
Blood (2022) 140 (Supplement 1): 195–197.
https://doi.org/10.1182/blood-2022-167177
Published: 2022
Journal Articles

Pan-Stakeholder Core Outcome Set (COS) Definition for Selected Hematological Malignancies - Results of the Harmony Alliance

Katharina M Lang, Tamás Bereczky, Natacha Bolanos, Ana Vallejo, Ananda Plate, Kathryn E. Morgan, Sophie Wintrich, Nick York, Gert J. Ossenkoppele, Brian J.P Huntly, Hartmut Döhner, Gilles Salles, Martin H. Dreyling, Silvia Montoto, Pieter Sonneveld, Jesus San-Miguel, Mario Boccadoro, Pierre Fenaux, Andrea Kündgen, Valeria Santini, Paolo Ghia, Sarka Pospisilova, Francesc Bosch, Katy Harrison, Jan Geissler, Yann Guillevic, Frederico Calado, Guillermo Sanz, Jesus Maria Hernández-Rivas, Paula Williamson, Ellen De Waal, Martje Barbus, Renate Schulze-Rath, Lars Bullinger
Journal: Blood
Blood (2021) 138 (Supplement 1): 5031.
https://doi.org/10.1182/blood-2021-145002
Published: 2021
Journal Articles

Investigating the Quality of Life of Patients with Acute Leukemia, with a Focus on Age and Patient-Reported Experience

Zack Pemberton-Whiteley, Samantha Nier, Jan Geissler, Sophie Wintrich, Bregje Verhoeven, Rita I O Christensen, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP, Esther Natalie Oliva, MD, Tatyana Ionova, Jennie Bradley, BA, Anne Rosemary Tate
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-141293
Published: 2020
Journal Articles

CML Patients' Views on Psychological Support throughout the Treatment-Free Remission Journey

Giora Sharf, Andreas Hochhaus, MD, Jan Geissler, Celia Marin, Zack Pemberton-Whiteley, Felice Bombaci, Rita I O Christensen, Bahija Gouimi, Mina Daban, Nigel B Deekes, Jennie Bradley
Journal: Blood
Blood (2019) 134 (Supplement_1): 2934.
https://doi.org/10.1182/blood-2019-123942
Published: 2019
Journal Articles

Identifying Differences in the Quality of Life of Patients with Acute Leukemia: A Global Survey

Zack Pemberton-Whiteley, Esther Natalie Oliva, MD, Jan Geissler, Sophie Wintrich, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP, Tatyana Ionova, PhD Professor, Anne Rosemary Tate, Jennie Bradley
Journal: Blood
Blood (2019) 134 (Supplement_1): 4785.
https://doi.org/10.1182/blood-2019-128818
Published: 2019
Journal Articles

Randomized, Open-Label, Multicenter, Phase 2 Study of Asciminib (ABL001) As an Add-on to Imatinib Versus Continued Imatinib Versus Switch to Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Have Not Achieved a Deep Molecular Response with Frontline Imatinib

Giuseppe Saglio, MD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Jan Geissler, Shruti Kapoor, Anne-Sophie Longin, Ayon Mukherjee, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5910.
https://doi.org/10.1182/blood-2019-124702
Published: 2019
Journal Articles

Factors Predicting Intentional Non-Adherence In Chronic Myeloid Leukemia: A Multivariate Analysis On 2546 Patients By The CML Advocates Network

Jan Geissler, Fabio Efficace, Felice Bombaci, Jan de Jong, Anthony Michael Gavin, Euzebiusz J Dziwinski, Mina Daban, Jana Pelouchová, Francesco Cottone, Joelle Guilhot, PhD, Giora Sharf
Journal: Blood
Blood (2013) 122 (21): 4023.
https://doi.org/10.1182/blood.V122.21.4023.4023
Published: 2013